The ROS1 Experts


The ROS1 researchers and clinicians listed on this page are the most familiar with ROS1+ cancers, treatments, and clinical trials. If you have questions about the next step in treating ROS1+ cancer, most of them available for second opinions or physician consults. Some offer remote second opinions (submit your medical records and have a consultation by phone), which are not covered by insurance.

D Ross Camidge, MD, PhD
University of Colorado, Denver, Colorado USA
Remote second opinion available


Jeffrey W. Clark, MD
Massachusetts General Hospital, Boston, Massachusetts, USA


Daniel B. Costa, MD, PhD
Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA


Robert C. Doebele, MD, PhD
University of Colorado, Denver, Colorado USA
Remote second opinion available


Sai-Hong Ignatius Ou, MD, PhD
University of California, Irvine, California, USA


Gregory J. Riely, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, New York, USA


Ravi Salgia, MD, PhD
City of Hope, Duarte, California, USA


Geoffrey I. Shapiro, MD, PhD
Dana-Farber Cancer Institute, Boston, Massachusetts, USA


Alice T. Shaw, MD, PhD
Massachusetts General Hospital, Boston, Massachusetts, USA


Ben Solomon, MBBS, PhD
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia


jurgenJürgen Wolf, MD
University Hospital of Cologne, Center for Integrated Oncology Köln Bonn, Köln, Germany


Last updated 03-Sep-2017